1. Home
  2. QURE vs CYD Comparison

QURE vs CYD Comparison

Compare QURE & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • CYD
  • Stock Information
  • Founded
  • QURE 1998
  • CYD 1951
  • Country
  • QURE Netherlands
  • CYD Singapore
  • Employees
  • QURE N/A
  • CYD N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • CYD Industrial Machinery/Components
  • Sector
  • QURE Health Care
  • CYD Industrials
  • Exchange
  • QURE Nasdaq
  • CYD Nasdaq
  • Market Cap
  • QURE 432.6M
  • CYD 493.2M
  • IPO Year
  • QURE 2007
  • CYD 1994
  • Fundamental
  • Price
  • QURE $6.65
  • CYD $12.01
  • Analyst Decision
  • QURE Buy
  • CYD
  • Analyst Count
  • QURE 6
  • CYD 0
  • Target Price
  • QURE $19.50
  • CYD N/A
  • AVG Volume (30 Days)
  • QURE 846.7K
  • CYD 16.4K
  • Earning Date
  • QURE 11-05-2024
  • CYD 08-12-2024
  • Dividend Yield
  • QURE N/A
  • CYD 3.15%
  • EPS Growth
  • QURE N/A
  • CYD 14.53
  • EPS
  • QURE N/A
  • CYD 1.17
  • Revenue
  • QURE $27,707,000.00
  • CYD $2,639,608,357.00
  • Revenue This Year
  • QURE $187.60
  • CYD $11.68
  • Revenue Next Year
  • QURE $51.90
  • CYD $4.06
  • P/E Ratio
  • QURE N/A
  • CYD $10.32
  • Revenue Growth
  • QURE N/A
  • CYD 15.32
  • 52 Week Low
  • QURE $3.73
  • CYD $7.85
  • 52 Week High
  • QURE $11.35
  • CYD $13.05
  • Technical
  • Relative Strength Index (RSI)
  • QURE 63.87
  • CYD 48.52
  • Support Level
  • QURE $6.01
  • CYD $11.99
  • Resistance Level
  • QURE $6.55
  • CYD $12.43
  • Average True Range (ATR)
  • QURE 0.54
  • CYD 0.33
  • MACD
  • QURE 0.18
  • CYD -0.09
  • Stochastic Oscillator
  • QURE 91.67
  • CYD 10.47

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: